TwinBeech Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-163,798
| Closed | -$5.1M | – | 941 |
|
|
2025
Q1 | $5.1M | Buy |
+163,798
| New | +$5.1M | 0.09% | 241 |
|
|
2024
Q4 | – | Sell |
-182,628
| Closed | -$5.17M | – | 886 |
|
|
2024
Q3 | $5.17M | Buy |
182,628
+71,919
| +65% | +$2.03M | 0.1% | 240 |
|
|
2024
Q2 | $2.92M | Buy |
+110,709
| New | +$2.92M | 0.06% | 286 |
|
|
2024
Q1 | – | Sell |
-567,250
| Closed | -$15.9M | – | 808 |
|
|
2023
Q4 | $15.9M | Buy |
567,250
+203,959
| +56% | +$5.73M | 0.26% | 111 |
|
|
2023
Q3 | $9.86M | Sell |
363,291
-46,418
| -11% | -$1.26M | 0.19% | 149 |
|
|
2023
Q2 | $12.6M | Buy |
+409,709
| New | +$12.6M | 0.25% | 124 |
|
|
2023
Q1 | – | Sell |
-430,613
| Closed | -$17M | – | 851 |
|
|
2022
Q4 | $17M | Buy |
+430,613
| New | +$17M | 0.32% | 86 |
|
|
2022
Q2 | – | Sell |
-178,798
| Closed | -$6.97M | – | 701 |
|
|
2022
Q1 | $6.97M | Buy |
178,798
+93,200
| +109% | +$3.63M | 0.31% | 97 |
|
|
2021
Q4 | $3.41M | Buy |
+85,598
| New | +$3.41M | 0.19% | 150 |
|
|
2021
Q3 | – | Sell |
-103,101
| Closed | -$4.23M | – | 730 |
|
|
2021
Q2 | $4.23M | Buy |
+103,101
| New | +$4.23M | 0.51% | 60 |
|